Loading clinical trials...
Loading clinical trials...
A Study to Investigate the Effects of JNJ-38518168 on Methotrexate Pharmacokinetics in Rheumatoid Arthritis Participants on a Stable Methotrexate Dose
Conditions
Interventions
JNJ-38518168 / MTX
Locations
4
United States
Anniston, Alabama, United States
Daytona Beach, Florida, United States
Duncansville, Pennsylvania, United States
Dallas, Texas, United States
Start Date
June 1, 2011
Completion Date
October 1, 2011
Last Updated
May 6, 2013
NCT06647069
NCT07484243
NCT06841562
NCT07268326
NCT07233655
NCT07029555
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions